FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/10/046166 [Registered on: 04/10/2022] Trial Registered Prospectively
Last Modified On: 03/10/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda
Other (Specify) 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   To Know the Role of Gambhari(Kashmari) and Yashtimadhu in Asrigdara(Dysfunctional Uterine Bleeding). 
Scientific Title of Study   A Comparative Clinico - Analytical Study of Kashmari Phala Churna And Yashtimadhu Moola Churna in Asrigdara. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Radhika Kumiya  
Designation  MD Scholar  
Affiliation  Rishikul Campus, Uttrakhand Ayurveda University,Haridwar 
Address  PG Department of Dravyaguna, Rishikul Campus, Uttarakhand Ayurveda University, Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  8739923979  
Fax    
Email  drradhikakumiya@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Dinesh Chandra Singh 
Designation  Professor and Head of The Department 
Affiliation  Rishikul Campus, Uttrakhand Ayurveda University,Haridwar 
Address  PG Department of Dravyaguna, Rishikul Campus, Uttarakhand Ayurveda University, Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  9411175362  
Fax    
Email  drdcschauhan@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Dinesh Chandra Singh 
Designation  Professor and Head of The Department 
Affiliation  Rishikul Campus, Uttrakhand Ayurveda University,Haridwar 
Address  PG Department of Dravyaguna, Rishikul Campus, Uttarakhand Ayurveda University, Haridwar

Hardwar
UTTARANCHAL
249401
India 
Phone  9411175362  
Fax    
Email  drdcschauhan@gmail.com  
 
Source of Monetary or Material Support  
Rishikul Campus, Uttarakhand Ayurved University 
 
Primary Sponsor  
Name  Rishikul Campus Uttarakhand Ayurved University 
Address  PG Department of Dravyaguna, Rishikul Campus,Uttarakhand Ayurveda University, Haridwar  
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Radhika Kumiya   Gurukul Campus  Room No.- 10,OPD of Department of Prasuti Tantra Evam Stri Roga,Gurukul Campus, Uttarakhand Ayurveda University
Hardwar
UTTARANCHAL 
8739923979

drradhikakumiya@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:N921||Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: Asrigdara (Dysfunctional Uterine Bleeding ), (2) ICD-10 Condition:N921||Excessive and frequent menstruation with irregular cycle. Ayurveda Condition: Asrigdara (Dysfunctional Uterine Bleeding ),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Comparator ArmDrugClassical(1) Medicine Name: Kashmari(Gambhari) fruit, Reference: Charak Samhita Sutrasthan 25/40, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Yashtimadhu root, Reference: Charak Samhita Sutrasthan 4/46, Route: Oral, Dosage Form: Churna/ Powder, Dose: 3(g), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 3 Months, anupAna/sahapAna: Yes(details: -Madhu), Additional Information: -
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  45.00 Year(s)
Gender  Female 
Details  1.Classical Symptoms of Asrigdara(Aartava Atipravariti,Angmarda,Vedana)
2.Continuous Vaginal Bleeding
3.History of Heavy Vaginal Bleeding
4.Increased Vaginal Bleeding with Irregularities in the Frequency of Menstrual Cycle  
 
ExclusionCriteria 
Details  1. Severe Anemia Patients
2. Systemic Disease - Bleeding
Disorder,Uncontrolled
Diabetes Mellitus,Hypertension,Heart
Disease,Thyroid Dysfunction.
3. Pelvic Disease - Fibroid ,Benign/Malignant
Tumors of Ovary, Sexual Transmitted Disease
4.Others Serious Medical & Surgical ill Patients
5.Patients with Intra Uterine Devices 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Alternation 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Relief in heavy menstrual bleeding.
2.Relief in Irregularities in the
Frequency of Menstrual Cycle.
3.Relief in pain during mensuration.

 
Observation of the patient during treatment for 3 consecutive menstrual cycles and follow up for another 2 consecutive menstrual cycles after completion of the treatment.Total duration is 5 month. 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in menstrual health and reproductive health of women.   1 year 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   01/11/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Nil 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Among the gynecological disorders Asrigdara is one of the most common menstrual bleeding associated with excessive menstrual bleeding with or without intermenstrual bleeding. It is a considerable health care burden for a women and has adefinite effect on her quality of life.In classical texts many preparation have been described for treatment and managment of Asrigdara, among from them ,the present study is a small effort to compare the efficiency of Kasmari(Gambhari ) phala churna and Yashtimadhu moola churna. in Ayurveda these to drugs are explained as hemostatic drugs in many bleeding disorders.     
Close